
Glimseg-P1 Tablet SR
Marketer
SAG Health Science Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimseg-P1 Tablet SR
DiaBeta-Comp SR tablets combine medications to effectively manage blood glucose. This formulation, used alongside diet and exercise, enhances glycemic control in adult patients with type 2 diabetes. It facilitates efficient insulin use, thus reducing blood sugar. Always adhere to your physician's prescribed dosage and regimen for DiaBeta-Comp SR. Taking it with food mitigates potential stomach discomfort. If a dose is missed, take it promptly; however, near the next scheduled dose, omit the missed one and resume the usual schedule. Never double the dose. Excessive intake can result in hypoglycemia (low blood sugar). Concomitant use with other diabetes medications, alcohol, or skipped meals increases the risk of hypoglycemia. Regular blood sugar monitoring is essential. Common adverse effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals should also seek medical counsel before use. Your doctor will assess kidney function before prescribing. Limit alcohol consumption, as it may amplify the risk of side effects.
Uses of Glimseg-P1 Tablet SR
Managing type 2 diabetes
Major Benefits of Glimseg-P1 Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimseg-P1 SR tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
Common Side effects of Glimseg-P1 Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimseg-P1 Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimseg-P1 SR tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
How Glimseg-P1 Tablet SR works:
Glimseg-P1 SR tablets contain a triple-action antidiabetic formulation: glimepiride, metformin, and pioglitazone. These medications employ distinct mechanisms to optimize blood sugar management when single or dual-agent treatments prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thus reducing blood glucose levels. Metformin, a biguanide, acts by reducing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimseg-P1 SR tablets with alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Glimseg-P1 Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against these risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Prolonged-release Glimseg-P1 tablets may pose a risk to breastfeeding infants. Available human data indicate potential transfer to breast milk, with possible adverse effects on the nursing child.
DrivingCAUTION
Impaired driving is possible with either hypoglycemia or hyperglycemia. Refrain from driving if these conditions arise.
KidneyCAUTION
Exercise caution when administering Glimseg-P1 SR tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician. Glimseg-P1 SR tablets are contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should exercise caution when using Glimseg-P1 Tablet SR; dosage modification may be necessary. Consult a physician for guidance. Glimseg-P1 Tablet SR is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glimseg-P1 Tablet SR :
Should you forget a dose of Glimseg-P1 Tablet SR, take it immediately if you remember. However, if your next dose is nearly due, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Glimseg-P1 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes medication |
